Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Recurrent Epithelial Cervical Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT02255097
What this trial is testing

Study of MK-3475 (Pembrolizumab) in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma After Treatment With Platinum-based and Cetuximab Therapy (MK-3475-055/KEYNOTE-055)

Who this might be right for
Head and Neck Squamous Cell Carcinoma
Merck Sharp & Dohme LLC 172
Not applicableUnknownNCT02119559
What this trial is testing

Circulating Tumor Cells as an Early Predictive head-and -Neck Squamous-cell Carcinoma

Who this might be right for
Metastatic Head-and-neck Squamous-cell Carcinoma
University Hospital, Montpellier 115
Very early researchStudy completedNCT03182959
What this trial is testing

Broccoli Sprout Extract in Preventing Recurrence in Patients With Tobacco-Related Head and Neck Squamous Cell Cancer

Who this might be right for
HNSCCHead and Neck CancerHead and Neck Squamous Cell Carcinoma+5 more
University of Arizona 6
Large-scale testing (Phase 3)Looking for participantsNCT06601335
What this trial is testing

AK112 Plus AK117 Versus Pembrolizumab in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (R/M HNSCC)

Who this might be right for
Head and Neck Squamous Cell Carcinoma
Akeso 510
Testing effectiveness (Phase 2)UnknownNCT03424291
What this trial is testing

A Retrospective Clinical Study of Apatinib in Combination With Radiotherapy / Chemotherapy Second-line and Above in the Treatment of Recurrent / Metastatic Head and Neck Squamous Cell Carcinoma

Who this might be right for
Head and Neck Squamous Cell Carcinoma
Henan Cancer Hospital 60
Large-scale testing (Phase 3)Ended earlyNCT04428333
What this trial is testing

Study of GSK3359609 With Pembrolizumab and 5-fluorouracil (5-FU)-Platinum Chemotherapy in Participants With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

Who this might be right for
Neoplasms, Head and Neck
GlaxoSmithKline 117
Testing effectiveness (Phase 2)Active Not RecruitingNCT06557889
What this trial is testing

Reduction in the Number of Chemotherapy Cycles in Combination With Pembrolizumab in First-line Treatment of PD-L1-positive Recurrent or Metastatic Head and Neck Squamous Cell Carcinomas

Who this might be right for
Squamous Cell Carcinoma of Head and Neck
Institut Claudius Regaud 86
Testing effectiveness (Phase 2)Study completedNCT00100789
What this trial is testing

S0329, Gemcitabine and Paclitaxel in Treating Patients With Persistent, Recurrent, or Metastatic Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
SWOG Cancer Research Network 67
Not applicableEnded earlyNCT01096381
What this trial is testing

Potential Biomarkers for Bevacizumab-Induced High Blood Pressure in Patients With Solid Tumor

Who this might be right for
Breast CancerCardiovascular ComplicationsColorectal Cancer+6 more
Vanderbilt-Ingram Cancer Center 8
Testing effectiveness (Phase 2)Ended earlyNCT06054477
What this trial is testing

Study of ALE.C04 in Patients With Head and Neck Cancer

Who this might be right for
Head and Neck CancerHead and Neck Squamous Cell Carcinoma
Alentis Therapeutics AG 21
Testing effectiveness (Phase 2)Study completedNCT00004901
What this trial is testing

Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Advanced Mouth Cancer

Who this might be right for
Head and Neck Cancer
Robert H. Lurie Cancer Center
Testing effectiveness (Phase 2)UnknownNCT05075122
What this trial is testing

Tolerability and Efficacy of UV1 Vaccine in Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma Planned for First-line Treatment With Pembrolizumab

Who this might be right for
Head and Neck Squamous Cell Carcinoma
Martin-Luther-Universität Halle-Wittenberg 75
Testing effectiveness (Phase 2)Study completedNCT02795195
What this trial is testing

Trail Evaluating Carbon Ion Radiotherapy (3 GyE Per Fraction) for Locally Recurrent Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Shanghai Proton and Heavy Ion Center 51
Large-scale testing (Phase 3)Looking for participantsNCT06064877
What this trial is testing

Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastatic (R/M) HPV Negative Head and Neck Squamous Cell Carcinoma

Who this might be right for
Metastatic Head-and-neck Squamous-cell CarcinomaRecurrent Head and Neck Squamous Cell Carcinoma
AVEO Pharmaceuticals, Inc. 410
Testing effectiveness (Phase 2)Study completedNCT05057247
What this trial is testing

Duvelisib Plus Docetaxel In Recurrent/Metastatic HNSCC

Who this might be right for
Squamous Cell Carcinoma of the Head and Neck (SCCHN)Recurrent Squamous Cell Carcinoma of the Head and NeckMetastatic Head and Neck Cancer+2 more
Glenn J. Hanna 26
Testing effectiveness (Phase 2)Study completedNCT02269943
What this trial is testing

Safety and Efficacy of CC-486 in Previously Treated Patients With Locally Advanced or Metastatic Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Neoplasms
Celgene 36
Early research (Phase 1)UnknownNCT02433626
What this trial is testing

Study of COTI-2 as Monotherapy or Combination Therapy for the Treatment of Malignancies

Who this might be right for
Ovarian CancerFallopian Tube CancerEndometrial Cancer+7 more
Critical Outcome Technologies Inc. 51
Not applicableUnknownNCT04196985
What this trial is testing

18F-FDG PET/CT Versus 18F-FDG PET/MRI in Detecting Locoregional Recurrence 3 Months After CRT in Head and Neck SCC

Who this might be right for
Head and Neck Squamous Cell Carcinoma
Turku University Hospital 40
Testing effectiveness (Phase 2)Study completedNCT00381706
What this trial is testing

Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer

Who this might be right for
Esophageal Cancer
Alliance for Clinical Trials in Oncology 245
Testing effectiveness (Phase 2)UnknownNCT04143984
What this trial is testing

Carbon-Ion Radiotherapy Plus Camrelizumab for Locally Recurrent Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Shanghai Proton and Heavy Ion Center 146
Next Page